Position in MRK
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$2,692,932
+$262,269 QoQ
Shares Held
22,387
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. MRK ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
This page
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,692,932 | 22,387 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $2,430,663 | 23,092 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,953,554 | 23,276 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $1,957,943 | 24,734 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $2,360,957 | 26,303 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,737,092 | 27,514 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,381,476 | 29,777 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,638,110 | 29,387 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,693,280 | 27,990 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $4,762,538 | 43,685 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $4,555,949 | 44,254 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,170,048 | 44,805 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,446,357 | 41,793 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,754,651 | 42,854 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,809,948 | 44,240 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,129,909 | 45,299 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $3,874,565 | 47,222 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,766,396 | 49,144 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $3,764,137 | 50,115 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,233,409 | 54,435 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,032,746 | 65,284 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,581,047 | 68,228 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $5,814,134 | 70,092 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,577,274 | 72,123 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $5,390,798 | 70,065 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||